convalescent plasma will be given emergency use authorization to treat COVID-19, something Trump has called a “major therapeutic breakthrough”.
Researchers are launched trials in April that involved the transfusion of blood components from people who have recovered from COVID-19 to those who are sick or at high risk. Called “convalescent-plasma therapy,” this technique can work even without doctors knowing exactly what component of the blood may be beneficial.
convalescent plasma will be given emergency use authorization to treat COVID-19, something Trump has called a “major therapeutic breakthrough”.
Researchers are launched trials in April that involved the transfusion of blood components from people who have recovered from COVID-19 to those who are sick or at high risk. Called “convalescent-plasma therapy,” this technique can work even without doctors knowing exactly what component of the blood may be beneficial.